China’s new home sales by value fell 7.6% in the first nine months from a year earlier, widening from the 7.0% drop in the first eight months, the National Bureau of Statistics said Monday.
Property investment declined 13.9% over January…
Category: 6. Business
-
Home Prices in China’s Major Cities Continued to Decline in September
Home Prices in China’s major cities fell at a slightly faster pace in September from the previous month, highlighting persistent weakness in the nation’s real estate market.
Average home prices across China’s 70 biggest cities declined…
Continue Reading
-
Dow Jones Top Markets Headlines at 9 PM ET: Stock Futures Rise Ahead of Major Week of Earnings | Luxury …
Stock Futures Rise Ahead of Major Week of Earnings
The economic highlight of the week will be the September consumer price index, coming out on Friday.
—-
Luxury Brands’ Stiffest Competition Is the Stuff They Have Already…
Continue Reading
-
OpenAI big chip orders dwarf its revenues — for now
A Bernstein Research analyst says Open AI CEO Sam Altman has the power to crash the global economy or take everyone ‘to the promised land’ as the startup behind ChatGPT races to build artificial intelligence infrastructure costing billions… Continue Reading
-
Access Denied
Access Denied
You don’t have permission to access “http://www.alvarezandmarsal.com/press-release/turnaround-industry-survey-signs-of-recovery-overshadowed-by-persistent-business-struggles” on this server.
Reference…
Continue Reading
-
Week Ahead for FX, Bonds: U.S. Inflation, PMI -2-
For September, retail sales, a key gauge of consumption, likely grew 3.0% on year, down from August’s 3.4% increase, the poll shows. Industrial production is estimated to have grown 5.3%, marginally above August’s 5.2%. Fixed-asset investment…
Continue Reading
-
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity USA – English APAC – English APAC – Traditional Chinese
– The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment…
Continue Reading
-
ESMO 2025: GFH375 Shows Potential Against KRAS G12D Pancreatic Tumours
Oncogenic KRAS mutations, particularly the G12D variant, are the most common drivers of pancreatic ductal adenocarcinoma (PDAC), accounting for roughly 40% of cases and predicting a poorer prognosis. This mutation is a crucial target for new…
Continue Reading
-
ESMO 2025: Multi Cycle Dosimetry of the Albumin Binding PSMA Ligand [¹⁷⁷Lu]Ludotadipep in Metastatic Castration Resistant Prostate Cancer: Phase II Trial Results – UroToday
- ESMO 2025: Multi Cycle Dosimetry of the Albumin Binding PSMA Ligand [¹⁷⁷Lu]Ludotadipep in Metastatic Castration Resistant Prostate Cancer: Phase II Trial Results UroToday
- ASTRO: New therapy delays progression of recurrent prostate cancer
Continue Reading
